Health and wellness platform FriskaAi announced an agreement with glucose monitoring specialist Dexcom to integrate data from Dexcom's G7 and G6 continuous glucose monitoring (CGM) Systems into the FriskaAi platform.
FriskaAi's platform leverages advanced AI and mobile technology to provide patients with individualized health insights and suggestions, giving them the ability to take control of their health in conjunction with clinicians.
Additionally, the FriskaAi mobile app integrates with Dexcom CGMs and other smart devices, as well as health apps, for analysis by FriskaAi's platform.
The data, along with other clinical data and studies, is continuously observed by AI-powered algorithms that warn the patient when action is advised.
It also generates reports that can be used by clinicians at the point of care.
Moreover, the company asserts that aggregated health data is also analyzed within the FriskaAi platform to help physicians identify trends and risks that exist in their patient populations.
"Dexcom’s pioneering CGMs are vital tools not only for diabetes management but also for informing broader care decisions," Shaji Nair, CEO of FriskaAi, said in a statement.
"FriskaAi is excited about the potential this integration with Dexcom presents to the physicians relying on our platform for chronic disease management and the patients seeking greater control over their health and wellness."
THE LARGER TREND
In July, the government of Ontario, Canada announced it would include the Dexcom G7 CGM System as part of the Ontario Drug Benefit program for eligible Ontarians who manage their diabetes with insulin.
That same month, Dexcom released an AI-powered photo meal logging feature to Stelo. Dexcom's Smart Food Logging feature allows users to log their meals.
Stelo and Dexcom G7 users can take a photo of their food in the app, where AI then identifies the ingredients and populates the meal description.
In May, Dexcom expanded its partnership with health-tracking ring maker Oura to provide Stelo users and ring wearers with metabolic health features, including meal insights and glucose data.
Through the partnership, users of Dexcom's continuous glucose monitor Stelo, which received FDA clearance in 2024, will have access to Meal and Glucose.
Through Meal, Oura Ring wearers can take a picture of their food through the Oura app, and AI-enabled food recognition and nutrition analysis will be used to provide users with insights on how their meals or snacks affect them throughout the day.
Glucose will provide ring-wearers with contextual graphs and insights to help them understand the connection between meals, daily movement, glucose levels, stress and tags through information collected through the Stelo device.
In April, Dexcom received FDA clearance for its G7 15 Day CGM System for people 18 and older with type 1, type 2 and gestational diabetes.
G7 15 Day has a 15.5-day wear time (including a 12-hour grace period) and lasts 15% longer than Dexcom G7, according to the company.
The system sends real-time glucose information to the Dexcom G7 app or receiver every five minutes via a sensor without the need for fingersticks or scanning.
In March, Nanowear announced a licensing and data partnership with Dexcom to integrate glucose data from the Dexcom G7 into its SimpleSense nanotechnology-enabled wearable.
Through the partnership, Nanowear ingests glucose data from Dexcom G7's continuous glucose monitoring system alongside Nanowear's cardiovascular biomarkers, which the company says will allow clinical researchers to obtain real-world and real-time cardiometabolic diagnostic assessments.
That same month, FriskaAi launched a slimmed-down version of its nutrition platform, Friska NutriAi.
The company said the version of Friska's nutrition management tool provides personalized dietary guidance to improve well-being, manage chronic diseases and improve health outcomes at no cost to consumers.
Additionally, the company noted that the version of Friska NutriAi leverages advanced AI algorithms to provide people with nutrition recommendations based on real-time data and health analytics.
